Systematic review of 18 observational studies (958 patients) of rheumatoid arthritis-associated ILD with pooled analysis: bDMARDs and tsDMARDs showed no significant overall change in FVC (-0.85%, p=0.29) or DLCO (+0.79, p=0.16).
Meta-analysisn = 958
Hilliquin et al. Effect of targeted therapies on pulmonary function in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis